Eiger BioPharmaceuticals Inc EIGR:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/05/22 EDT
8.75quote price arrow down-0.90 (-9.33%)
Volume
728,382
52 week range
3.53 - 10.02
Loading...
  • Open8.73
  • Day High9.50
  • Day Low8.63
  • Prev Close9.65
  • 52 Week High10.02
  • 52 Week High Date03/23/22
  • 52 Week Low3.53
  • 52 Week Low Date01/24/22

Key Stats

  • Market Cap378.18M
  • Shares Out43.22M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.67
  • YTD % Change68.59

KEY STATS

  • Open8.73
  • Day High9.50
  • Day Low8.63
  • Prev Close9.65
  • 52 Week High10.02
  • 52 Week High Date03/23/22
  • 52 Week Low3.53
  • 52 Week Low Date01/24/22
  • Market Cap378.18M
  • Shares Out43.22M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.67
  • YTD % Change68.59

RATIOS/PROFITABILITY

  • EPS (TTM)-2.50
  • P/E (TTM)-3.50
  • Fwd P/E (NTM)-4.15
  • EBITDA (TTM)-82.664M
  • ROE (TTM)-76.80%
  • Revenue (TTM)11.17M
  • Gross Margin (TTM)92.82%
  • Net Margin (TTM)-768.27%
  • Debt To Equity (MRQ)32.89%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Eiger BioPharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the development of therapies to treat and cure Hepatitis Delta Virus (HDV), the severe form of viral hepatitis, and other serious diseases. Its clinical product candidates include Lonafarnib (LNF) for HDV, Peginterferon Lambda (lambda) for HDV and Covid-19, Avexitide in Post-Bariatric Hypoglycemia (PBH) and Avexitide in Congenital Hyperinsulinism (CHI). Lambda is a...
Thomas Dietz Ph.D.
Independent Chairman of the Board
David Cory
President, Chief Executive Officer, Director
Sriram Ryali
Chief Financial Officer
Christopher Kurtz
Chief Technical Officer
Eldon Mayer III
Executive Vice President, Chief Commercial Officer
Address
2155 Park Blvd
Palo Alto, CA
94306-1543
United States

Top Peers

SYMBOLLASTCHG%CHG
PHAT
Phathom Pharmaceuticals Inc
7.25+0.21+2.98%
HUMA
Humacyte Inc
3.50+0.07+2.04%
VRDN
Viridian Therapeutics Inc
13.65+0.05+0.37%
LXRX
Lexicon Pharmaceuticals Inc
2.83+0.14+5.20%
AKRO
Akero Therapeutics Inc
13.78+0.99+7.74%